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Abstract
Background: Over 133,000 children present to hospitals with Acute Encephalitis Syndrome (AES) annually in Asia. Japanese
encephalitis (JE) accounts for approximately one-quarter of cases; in most cases no pathogen is identified and management
is supportive. Although JE is known to result in neurological impairment, few studies have examined the wider impact of JE
and AES on patients and their families.
Methodology/Principal Findings: Children (aged 1 month–14 years) with AES were assessed 5–12 months after discharge
from two Nepali hospitals. Assessment included clinical examination, the Liverpool Outcome Score (LOS) - a validated
assessment of function following encephalitis, questionnaires about the child’s social participation since discharge, and out-
of-pocket costs to the family. Children were classified as JE or ‘other AES’ based on anti-JE virus antibody titres during acute
illness. Contact was made with the families of 76% (73/96) of AES children. Six children had died and one declined
participation. 48% (32/66) reported functional impairment at follow-up, most frequently affecting behaviour, language or
limb use. Impairment was more frequent in JE compared to ‘other AES’ cases (68% [13/19] versus 40% [19/47]; p = 0.06). 49%
(26/53) had improvement in LOS between discharge and follow-up. The median out-of-pocket cost to families, including
medical bills, medication and lost earnings was US$ 1151 (10 times their median monthly income) for children with severe/
moderate impairment and $524 (4.6 times their income) for those with mild/no impairment (P = 0.007). Acute admission
accounted for 74% of costs. Social participation was limited in 21% of children (n = 14).
Conclusions/Significance: Prolonged functional impairment was common following AES. Economic impact to families was
substantial. Encouragingly, almost half the children improved after discharge and most reported sustained social
participation. This study highlights a need for long-term medical support following AES. Rationalisation of initial expensive
hospital treatments may be warranted, especially since only supportive treatment is available.
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Introduction
In Asia more than 133,000 children suffer Acute Encephalitis
Syndrome (AES) annually [1]. The most commonly identified
cause of AES in Nepal and Asia is Japanese encephalitis (JE) virus
which accounts for around one quarter to one third of cases [2,3].
Both JE and AES exhibit a higher case frequency among children
compared with adults [1,2,4,5]. More than 20,000 children are
thought to die from JE annually, and many more suffer
neurological impairment [4]. A variety of infectious agents and
immune mediated processes, such as acute demyelinating
encephalomyelitis (ADEM), can cause encephalitis [6]. Recent
studies in Vietnam [7], Papua New Guinea [8] and England [9]
found no specific cause for 59%, 63% and 37% of paediatric cases
respectively, despite comprehensive diagnostic testing.
Studies of outcome among JE patients report widely varying
results, with death in 4–30% and long term neurological
impairment in 22–94% [10–16]. For children with AES in Asia,
death is reported in 4–29% of cases and functional impairment in
2.9–25% [3,8,10,17–19]; however few studies of AES have
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examined outcome beyond 3 months or provided detail regarding
the types of neurological impairment experienced. This is
surprising given more children have AES of unknown cause than
have JE.
Our previous work identified a large spectrum of behavioural
disturbances and impaired school performance following JE [11].
However, no studies have specifically assessed limitations in a
child’s ability to participate in school, social and everyday life
activities following AES.
Children with disabilities can have limited participation in
everyday life and social activities. Participation is affected by
motor and cognitive function, communication skills, age, gender
and environmental factors [20]. Reduced participation has been
shown to have a negative impact on quality of life in disabled
children [21]. Improving inclusion and participation for people
with disabilities is the ultimate aim of the World Health
Organization’s ‘Community Based Rehabilitation’ programme
[22]. Although there are scores for assessing participation of
children with disability in high income countries [20,21,23,24], as
far as we are aware, there is no such score for use in a resource
poor setting.
Healthcare in Nepal, as in many low income countries, is not
free. Patients are usually billed for medical care in both
government and private hospitals. To date, there have been no
studies which have looked at the costs of AES in a low resource
country. A few studies have evaluated the economic cost of JE.
Studies have estimated costs associated with JE through informa-
tion from hospital administrators or neurologists, as well as by
extrapolation of costs from other infectious conditions [25–27].
One study in Cambodia also ascertained ‘out of pocket’ costs to
the family, by interviewing carers of children with JE up to 90 days
after discharge from hospital [28].
JE is a vaccination priority in Nepal. In 2009 the JE vaccine was
introduced into the child routine immunization programme in 16
districts in Nepal where JE is endemic (there are 75 districts in
total) [29]. Despite this, there are currently no data regarding the
economic burden of JE or AES. Establishing these costs is an
important step towards assessing the cost effectiveness of
management options for AES in Nepali children.
The aim of this study is to provide an overview of the functional
impairment, social participation and economic costs experienced
by Nepali children and their families following JE and other AES
illness.
Methods
Ethics statement
Ethical approval for the study was granted by the Institutional
Review Committee of Kanti Children’s Hospital, the Nepal
Health Research Council and the Ethics Review board of the
Liverpool School of Tropical Medicine. Written informed consent
was obtained from the parents or guardians of all children who
participated in the study.
Setting and recruitment
Children with suspected encephalitis were recruited from two
public hospitals in Nepal. The hospital sites were: Kanti Childrens’
Hospital (KCH), Kathmandu, the only government-run children’s
hospital in Nepal and BP Korala Institute of Health Sciences
(BPKIHS), a large autonomous institution with a busy paediatric
department in Dharan, Eastern Nepal. Children aged 1 month–14
years, who fulfilled the clinical and laboratory criteria for Acute
Encephalitis Syndrome, based on the World Health Organization
definition (below), were recruited into the study. Participants were
assessed prior to hospital discharge, and were then followed-up
once 5–12 months later, during April–July 2011.
The following criteria, based on the WHO definition [30], were
used:
N Acute Encephalitis Syndrome (AES): Acute fever (less than 14
days duration) with altered mental state and/or new onset
seizures (excluding simple febrile convulsions) with no positive
identification of non-viral pathogens (e.g. bacteria or parasites)
in the CSF or blood.
N AES - Confirmed JE: AES with IgM antibodies ($40 units) to
JEV in a single (CSF and/or serum) sample as detected by
IgM-capture Enzyme linked immunosorbent assay (ELISA).
N ‘other AES’: AES where the above criteria were not met
N ‘other AES - JE negative’: AES with an absence of anti-JEV
IgM antibodies based on a negative test for a sample
collected $day 10 of illness onset.
N ‘other AES - JE status unknown’: AES where there was no
testing for anti-JEV IgM antibodies or samples were taken
too early in the illness to exclude JE.
Assessment procedures
Assessment at hospital discharge involved a clinical examination
of the child and interview with the family to complete the
Liverpool Outcome Score questionnaire (described below). Clin-
ical review involved a neurological examination which included
assessment of coma status using the modified Glasgow coma scale
for infants and children.
One follow-up assessment was undertaken for each child, 5–12
months after hospital discharge (median 8 months). Assessment at
follow up involved a clinical examination of the child and three
questionnaires with the family or carers (described below). Carers
were contacted by telephone and invited to re-attend the hospital
Author Summary
More than 133,000 children present annually to hospitals
in Asia with clinical features of acute brain infection (Acute
Encephalitis Syndrome [AES]). Japanese encephalitis ac-
counts for one-quarter of cases in Asia. With no specific
treatments for AES, management is largely supportive. AES
commonly causes neurological problems. However, few
studies have examined long-term outcome or the eco-
nomic cost of AES. We followed up 72 Nepali children 5–12
months after acute hospital admission for AES and studied
their neurological function, social participation and the
out-of-pocket costs to the family. At follow-up, 6 children
had died and 48% of survivors had impaired function.
Behaviour, language or limb impairments were common.
Encouragingly, almost half the children reported improved
function at follow-up compared to hospital discharge. The
economic impact was substantial; $1151 US dollars (10
times their monthly income) among families with children
suffering severe/moderate impairment. Acute admission
represented 74% of total costs. Few families reported
limitations in their child’s social participation. The func-
tional problems experienced by these children highlights
their need for long-term medical support. The substantial
economic costs to families suggest rationalisation of acute
care costs may be warranted. Families reported their child
maintaining social participation, implying a positive
attitude to social engagement.
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with their children. Families who agreed to participate, but did not
wish to attend the hospital, were invited to complete the
assessment over the telephone (economic costs and findings from
clinical examination were not obtained for these participants). The
assessments were performed by local clinical research officers
trained in the use and delivery of the questionnaires.
1) Liverpool Outcome score (LOS); The LOS is a simple validated
tool for assessing functional impairment in children following
acute encephalitis [31]. The LOS includes questions about the
functional impairment of the child, comparing their child’s
function to community peers of the same age [31]. The child’s
outcome classification is defined by their lowest score achieved
for any of the 15 domains assessed. A score of 5, 4, 3 or 2,
corresponds to an outcome classification of no, mild,
moderate or severe functional impairment respectively. Death
was scored as 1. Each child was also assigned a ‘mean LOS’
by adding together the scores for each question and dividing
by the number of questions asked. Mean score ranged from 2–
5. A lower score indicates more severe functional impairment.
2) Child and adolescent scale of participation (CASP); the impact of
AES on the child’s participation in everyday life and social
activities was assessed using a questionnaire based on the
CASP. The original CASP, composed of 20 questions, asks
about participation in the home, the community and in
school. It has been validated and used among American
children with acquired brain injury [23,32]. The content of
the CASP was modified for use in this study following
consultation with local Nepali paediatricians, other health
care workers, and parents. This modification involved the
exclusion of questions which overlapped with the LOS or
were agreed to be culturally inappropriate (Questionnaire S1).
The remaining questions (n = 10) asked about social partic-
ipation at home (n = 4), participation in the community (n = 3)
and participation at school (n = 3). Parents were asked to
compare their child to community peers of the same age. A
question was regarded as age appropriate if the parents/
guardians reported that community peers of the same age as
their child participated in the activity (e.g. attended school).
Each question was scored from 5-2: 5 - age expected
participation, 4 - somewhat limited participation, 3 - very
limited participation and 2 - unable to participate. Questions
regarded as age inappropriate were not scored. The mean
CASP score was calculated by adding together the scores for
each question and dividing by the number of age appropriate
questions asked. Mean score ranged from 2–5. A lower score
indicates more limited social participation.
3) Economic questionnaire; The costs of AES paid by each child’s
family, termed out-of pocket costs, was assessed using an
economic questionnaire produced in collaboration with local
paediatricians, other health care workers, and parents
(Supplementary File S2). The first section of the questionnaire
consisted of a short household survey based on content from
the Nepal Living Standards Survey 2 [33]. This provided
baseline information on parents’ level of education and
household income. Level of education was scored 1–9
corresponding to: 1- no formal schooling, 2- incomplete
primary, 3- complete primary, 4- incomplete secondary, 5-
complete secondary education and 6–9 different levels of
higher education (Questionnaire S2). Total monthly house-
hold income was calculated by adding income in wages and
any income earned ‘in kind’, i.e. paid in goods, or food
produced for personal consumption. The second section of the
questionnaire included questions about out-of-pocket costs to
the family secondary to the child’s illness. Acute costs included
the hospital bills for the child’s original admission, such as
hospital bed, medication and investigations. Acute non-
medical costs included transport to hospital, accommodation
and food for the family during the acute admission. Income
lost by the carers due to missing work while their child was
admitted was also estimated. Post-discharge costs included
purchase of medication and medical aids, and transport costs
to purchase medication or attend appointments with medical
doctors or traditional healers. The total cost of AES illness was
calculated by adding acute admission and post-discharge costs
for each participant. Values were recorded in Nepalese rupees
(NPR), the local currency, but converted into United States
dollars (US$) using the exchange rate for 2011 from the
International Monetary Fund (1 US$=78.3 NPR).
4) Clinical Examination; When children attended the follow-up
assessment at the hospital, they underwent a full general and
neurological examination. This information was used to
confirm the history and findings from the LOS.
Statistical analysis
Data was entered in to Microsoft Excel and descriptive analyses
performed. For statistical tests of difference and correlations,
analysis was undertaken using SPSS version 18. For binary data,
Fisher’s exact test was used. For categorical and non-parametric
data, the Mann Whitney U test was used. Agreement between
mean LOS and CASP scores among the follow-up participants
were measured by initially generating a Bland Altman plot and
then computing the limits of agreement [34]. These limits were
defined as the mean difference between the scores 62 standard
deviation of the difference. The proportion of scores that fell
within the limits of agreement was calculated. For all data, a two
sided test at the 95% confidence level was used to define statistical
significance. No assumptions were made about the outcomes of
participants who were lost to follow-up.
Results
Participant baseline characteristics
Ninety-six children with AES, including 34 with confirmed JE,
were discharged alive, of whom 55 were followed up in person and
11 by telephone interview (Table 1). Six subjects died prior to
follow-up, 23 families could not be contacted and 1 declined
participation (Fig. 1). The median age for the 72 children with
whom contact was made was significantly higher than for the 24
that were not (9 [range: 1–14] versus 6 [1–14] years; p = 0.029).
There were no other significant differences between groups
(Table 1). There was no difference in the median follow-up
interval between those with confirmed JE and ‘other AES’ (8
[range: 7–12] versus 8 [6–10] months; p= 0.63) or those with
severe or moderate (LOS 2/3) versus mild or no functional (LOS
4/5) impairment (8 [range: 5–10] versus 8 [5–12]; p = 0.14).
Participants came from four of the five health regions and 31 of
the 75 health districts across Nepal.
Functional impairment following AES
Thirty-two (48%) of the 66 children followed-up had functional
impairment (LOS 2–4). Impairment was more common in JE than
‘other AES’ cases (68% [13/19] versus 40% [19/47]; p = 0.06).
Among the ‘other AES’ cases, there were no significant differences
between the ‘other AES-JE negative’ and ‘other AES-JE status
unknown’ groups in the proportion of patients that died after
discharge or exhibited functional impairment (Table 2).
Functional, Social & Economic Cost of Encephalitis
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Types of neurological impairment following AES
The most frequently reported problems following AES were
behavioural disturbance, language problems, including both
expressive and hearing/receptive language difficulties, and reduced
limb function (Fig. 2). Although neurological sequelae were more
common in those with confirmed JE, the types of impairment were
similar in children with confirmed JE and other AES.
Recovery profile following AES
Twenty-six (49%) of 53 participants had a better LOS at follow-
up than discharge, with 9 (17%) moving from a classification of
severe functional impairment (LOS 2) to moderate functional
impairment or better (LOS 3–5) and of these, 5 (10%) making a
full recovery (LOS 5). Seventeen (32%) children had the same
LOS at discharge and follow-up. Nine (17%) participants had a
worse LOS at follow-up, of whom 3 had died. Three additional
children, for whom no discharge LOS was available, died during
the follow-up period. Overall, 12 (21%) of 56 subjects had a worse
LOS since discharge.
Most neurological impairments were less common at follow-up
compared to hospital discharge. Impairments of expressive speech
(10/50 [20%] vs. 21/50 [42%]; p = 0.03) or lower limb function
(6/50 [12%] vs. 19/50 [35%]; p = 0.005) were significantly less
frequently reported at follow-up compared to discharge. However,
behavioural disturbance, hearing/receptive language problems,
and uncontrolled seizures were reported more frequently at follow-
up than at discharge (Fig. 3). Use of healthcare services was not
specifically investigated during this study, but two families reported
involvement of a physiotherapist to assist with their child’s motor
problems.
Economic impact of AES
For the 54 families who completed the economic questionnaire;
41 (79%) of 52 fathers and 22 (41%) of 54 mothers reported ever
receiving any primary school education. Most families (40/54
[74%]) reported residing in a rural area. The occupation most
frequently reported was farming.
The median monthly household income, which included
income in the form of goods received or produced for personal
consumption, was US$ 115 (range: 11–575). With a median
household size of 6 individuals, the annual estimated income per
family member was US$ 230.
The median total out-of-pocket cost of AES to the family (which
included costs associated with acute hospital admission and up to
Figure 1. Flow diagram of study participants’ recruitment and follow-up. All children admitted to hospital fitting WHO criteria for AES who
were alive at discharge were attempted to be followed-up (n = 96). Seventy-two families were successfully contacted. Among these families, six
children had died and 1 declined to participate further. The remaining 66 children participated in follow-up.
doi:10.1371/journal.pntd.0002383.g001
Table 1. Baseline characteristics for all patients with Acute Encephalitis Syndrome eligible for study inclusion.
All eligible AES patients Followed up Not Followed up
No. patients in each group 96 72 24
Confirmed JE 31 (32.9) 22 (30.6) 9 (37.5)
Other AES 65 (67.7) 50 (69.4) 15 (62.5)
Male 58 (60.4) 45 (62.5) 13 (54.2)
Age, years 7.5 (1–14) 9 (1–14) 6 (1–14)*
Discharge GCS` 15 (3–15) 15 (3–15) 15 (3–15)
Discharge LOS" 3 (2–5) 3 (2–5) 3 (2–5)
Characteristics presented as number (%) or median (range).
AES, Acute Encephalitis Syndrome; No., number; GCS, modified Glasgow coma scale (score 3–15); LOS, Liverpool Outcome Score (1 [died] – 5 [no impairment]); na, not
applicable.
*Significant difference in the median age among patients Followed and Not Followed up, p = 0.029.
`Discharge GCS was not available for 3 patients who were followed up.
"Discharge LOS was not available for 25 patients (19 followed up and 6 not).
doi:10.1371/journal.pntd.0002383.t001
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12 months after discharge) was US$ 618 (range: 140–3959), which
was 5.4 times the median monthly family income. The median
total cost of acute hospital admission, including transportation,
hospitals bills, carers accommodation, food and loss of earnings
was US$ 473 (range: 52–3831), which was 4 times the median
monthly income (Table 3). For the 15 carers who gave a
breakdown of hospital bills, medication was the largest itemised
expense, with a median cost of US$ 243 (range: 27–1277) per
child; representing 57% of their admission cost.
All families reported direct costs associated with the acute
hospital admission. The majority of families (46/53 [87%]) had to
borrow money to cover the cost of acute admission and 8/53
(15%) had to sell an asset. Most carers (44/54 [81%]) missed work
during their child’s acute illness, with a median of 15 days (range:
4–45) missed and US$ 38 (range: 0–192) of income lost. Some
Table 2. Outcome for all Acute Encephalitis Syndrome patients included in the study.
All AES patients Confirmed JE Other AES Subgroups of ‘Other AES’ P value
JE negative JE status unknown
Total no. of patients in each group 72 22 50 31 19 -
Died post discharge (LOS 1) 6 (8.3) 3 (13.6) 3 (6.0) 2 (6.4) 1 (5.3) 0.36
Alive at follow-up 66 19 47 29 18 -
Any impairment at follow-up (LOS 2, 3, 4) 32 (48.5) 13 (68.4) 19 (40.4) 13 (44.8) 6 (33.3) 0.06
Severe impairment (LOS 2) 7 (10.6) 4 (21.0) 3 (6.4) 3 (10.3) 0 (0) 0.10
Moderate impairment (LOS 3) 9 (13.6) 4 (21.0) 5 (10.6) 3 (10.3) 2 (11.1) 0.27
Mild impairment (LOS 4) 16 (24.2) 5 (26.3) 11 (23.4) 7 (24.1) 4 (22.2) 1.00
No Impairment (LOS 5) 34 (51.5) 6 (31.6) 28 (59.6) 16 (55.2) 12 (66.7) 0.06
Clinical outcome for all Acute Encephalitis Syndrome patients included in the study. Outcomes presented as number in each group with proportion (%). Where
outcome involved death, the denominator was based on total number of families contacted. Otherwise denominator was based on the number of patients alive at
follow-up in the group. P values correspond to differences between ‘Confirmed JE’ and ‘Other AES’ groups across categories of impairment. Significance calculated
using Fisher’s exact test.
AES, Acute Encephalitis Syndrome; No., number; LOS, Liverpool Outcome Score (1 [died] – 5 [no impairment]).
doi:10.1371/journal.pntd.0002383.t002
Figure 2. Comparison of neurological impairment experienced
by children at follow-up classified with JE or ‘Other AES’. Graph
displays proportions (%) of the different types of neurological
impairment experienced by children that were alive at follow-up after
hospitalisation with AES (n = 66). Children were classified as suffering
from JE or ‘Other AES’ based on their anti-JE virus antibody titres
measured during acute admission (see Methods). Neurological impair-
ment was identified by reviewing clinician based on the history. White
bars; JE patients (n = 19). Black bars; ‘other AES’ patients (n = 47).
doi:10.1371/journal.pntd.0002383.g002
Figure 3. Comparison of neurological impairment experienced
by children with AES at discharge and at follow-up. Graph
displays proportions (%) of the different types of neurological
impairment experienced by children alive at discharge and at follow-
up who had a Liverpool Outcome Score measured at both time-points
(n = 50). Neurological impairment was identified by reviewing clinician
based on the history. White bars; Problem at follow-up. Black bars;
Problem at discharge. * Significant difference (P,0.05) in the
proportion of children who exhibited a specific type of neurological
impairment at discharge and at follow-up. Significance was measured
by Fisher’s exact test.
doi:10.1371/journal.pntd.0002383.g003
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carers (8/54 [15%]) missed work but did not lose income; some
reasons included being granted paid leave, or that they had
finished cultivation on their farm.
The costs after discharge were much lower than during acute
admission. Forty of 54 (74%) participants reported out-of-pocket
costs following their child’s discharge. Their median expenditure
was US$ 32 (range: 0–3004).
Purchase of medication was the most frequent out-of-pocket
expenditure, reported by 29 (60%) of 48 families (median cost US$
32 [range: 1–255]). Nineteen (35%) of 54 families reported taking
time off work after the child’s discharge. The median estimated
income lost among these families was US$ 51 (range: 0–460). The
median number of days missed was 30 (range: 4–250).
Influence of functional impairment on economic impact
The total median cost of AES was significantly higher for
children with severe or moderate functional impairment compared
to children with mild or no functional impairment at follow-up
(US$ 1151 [range: 254–3959] versus 524 [range: 140–1679];
p = 0.007). These total out-of-pocket costs corresponded to 10 and
4.6 times the median monthly income of the participants’ families.
The former group also had higher admission costs (US$ 754
[range: 179–3831] versus 447 [52–1277]; p= 0.048) and costs
after discharge (US$ 51 [0–3004] versus 31 [0–294]; p= 0.28).
A higher proportion of carers for children with severe/moderate
functional impairment took time off work after discharge
compared to carers for children with mild/no functional
impairment (10/15 [67%] versus 9/39 [23%]; p = 0.004). The
carers of children with severe/moderate functional impairment
also took longer median time off work (median 60 [range: 7–250]
versus 23 [4–60] days; not significant) and lost more income
(median US$ 51 [range: 0–460] versus 45 [0–319]; not significant).
Details are provided in Table 3.
Among all participants, four (two with severe/moderate
impairment and two with mild/no impairment) reported unusu-
ally high post-discharge costs with one child taken to India for
treatment, at a cost of US$ 3003, one transferred to another
hospital at a cost of US$ 255 and two taken to a traditional healer
at median cost of US$ 179. Removing these cases, carers for
children with severe/moderate functional impairment still report-
ed significantly higher total out-of-pocket costs (p = 0.025). There
were no significant differences in household income or education
levels of the parents between children with severe/moderate
functional impairment compared to those with mild/no impair-
ment following AES (Table 3).
Participation in everyday activities following AES
Overall, 14 (21%) of the 66 carers who completed the CASP
reported limitations in their child’s participation either within the
home, the community or the school environment. Five (8%) of
sixty six children had limitations in all three environments. Among
school aged children, 10 (16%) of the 62 subjects reported
limitations with participation at school, of which 7 had stopped
attending school. Among school aged children with moderate or
Table 3. Educational and economic data among the 54 families interviewed, grouped by Liverpool Outcome Score.
All LOS 2 or 3 LOS 4 or 5
Number of participants in each group 54 15 39
Proportion of fathers who ever attended school 41/52 (79) 10/15 (67) 31/37 (84)
Proportion of mothers who ever attended school 22/54 (41) 5/15 (33) 17/39 (44)
Median number of household members 6 (2–16) 6 (4–16) 5 (2–16)
Median household income, US$ 115 (11–575) 115 (11–511) 112 (35–575)
Median total cost of admission, US$ 473 (52–3831) 754 (179–3831)* 447 (52–1277)
Median cost of medication, US${ 243 (27–1277) 268 (102–1277) 236 (27–702)
Median admission length, days 9 (2–34) 11 (3–34) 9 (2–31)
Proportion sold an asset for admission costs 8/53 (15) 2/15 (13) 6/38 (16)
Proportion borrowed money for admission costs 46/53 (87) 12/15 (80) 34/38 (89)
Proportion missed work during acute illness 44/54 (81) 13/15 (87) 31/39 (79)
Median work days missed during acute illness 15 (4–45) 16 (7–45) 15 (4–35)
Median earnings lost during acute illness, US$ 38 (0–192) 38 (0–153) 38 (0–192)
Proportion who spent money after discharge 40/54 (74) 11/15 (73) 29/39 (74)
Median spent after discharge, US$ 32 (0–3004) 51 (0–3004) 31 (0–294)
Median spent on medication after discharge, US$" 32 (1–255) 51 (5–255) 32 (1–255)
Proportion who missed work following child’s discharge 19/54 (35) 10/15 (67)1 9/39 (23)
Median work days missed after discharge 30 (4–250) 60 (7–250) 23 (4–60)
Median earnings lost after discharge (of those who missed work, US$ 51 (0–460) 51 (0–460) 45 (0–319)
Median total costs (admission and after discharge), US$ 618 (140–3959) 1151 (254–3959)` 524 (140–1679)
Results presented as number in each group with proportion (%) or Median (range) grouped by Liverpool outcome score (LOS) at follow-up; LOS 2 or 3 represents Severe
or Moderate impairment; LOS 4 or 5 represents Mild or No Impairment; US$, United Sates Dollars.
*1`Significant difference in median values or proportion of patients between ‘LOS 2 or 3’ and ‘LOS 4 or 5’ groups (p = 0.048*, p = 0.0041 and p= 0.007` respectively).
Significance measured via Mann Whitney U or Fisher’s Exact Test.
{15 participants provided specific information on admission medication cost.
"29 participants provided information on discharge medication costs.
doi:10.1371/journal.pntd.0002383.t003
Functional, Social & Economic Cost of Encephalitis
PLOS Neglected Tropical Diseases | www.plosntds.org 6 September 2013 | Volume 7 | Issue 9 | e2383
severe impairments, 7 (50%) of the 14 children were still attending
school full time. Reasons for reduced school participation included
seizures, mobility, behavioural and financial problems.
We anticipated that children who exhibited limited functional
impairment (relatively high LOS) would also exhibit limited
impairment in their social participation (relatively high CASP
score). Where children had both assessments undertaken at follow-
up, we compared the mean CASP scores against their corre-
sponding mean LOS to assess their levels of agreement.
Overall, the mean CASP score demonstrated reasonable
agreement against the mean LOS. Sixty (91%) of 66 children
assessed by both scores at follow-up exhibited mean CASP scores
and LOS that fell within the limits of agreement during Bland-
Altman analysis (Figure 4). Among the six participants that fell
outside these limits, five families reported their child having lower
social participation (based on the CASP) than may be expected for
their child’s reported functional ability (based on the LOS).
Reviewing the parental responses for these children; two had
behavioural problems that limited social participation; one child
had visual impairment; one child no longer attended school due to
the family’s worse financial circumstances since the AES illness;
and one child no longer attended school due to moderate mobility
impairment since the AES illness, compounded by the family
living relatively far from the school.
One family reported their child having higher social participa-
tion than may be expected for their child’s functional ability. The
child was reported to have developmental delay prior to AES
illness.
Discussion
This is the first study to examine the functional, economic and
social impact of AES in parallel following hospital discharge.
Although this study was undertaken in Nepal, AES is prevalent in
Asia and so we would expect the findings to be of relevance
throughout the area [1]. We show a substantial impact of AES on
a child’s function several months after their acute illness. There
were considerable out-of-pocket costs of AES illness to families,
with the median cost being more than five times their estimated
monthly income. The predominant costs were linked with the
acute hospital admission. Total costs were significantly higher for
children with severe or moderate functional impairment compared
to those with mild or no impairment. Encouragingly, among
participants in whom LOS was measured at discharge and follow-
up, 49% reported improved function up to 12 months later.
Despite the high levels of functional impairment, few families
reported limitations in their child’s social participation.
This study highlights the high burden of disability following
AES illness of undetermined cause. Almost one-tenth of children
died following discharge; around half of the survivors exhibited
functional impairment up to 12 months after hospital discharge.
Proportionally, impairment was more frequent among JE
confirmed AES cases compared to ‘other AES’ cases, as seen in
previous studies [3,10,19]. This finding highlights the value of JE
vaccination programmes. However, in terms of absolute numbers
more children suffered functional impairment in the ‘other AES’
group’. The types of impairment reported in the JE and ‘other
AES’ groups were similar. In line with previous JE studies,
behavioural difficulties were most frequently reported at follow-up
[11,35]. Language or limb movement difficulties were next most
frequently reported.
Function improved at follow-up in almost half of the
participants; a fifth exhibited a worse outcome; and a third
exhibited the same outcome. These findings for AES, are in line
with the results from our previous study of long-term outcome for
JE among Malaysian children [11]. Although the use of health
services was not a specific focus of this study, few families reported
involvement with health professionals after discharge. Input from
psychologists, speech and language therapists, physiotherapists and
occupational therapists may be useful to children with AES when
locally available. The changes in patients’ levels of impairment
following hospital discharge, emphasises the clinical need for
follow-up of AES patients. The results also provide useful
information for health care professionals when discussing the
prognosis of AES with Nepali patients.
The most striking finding of this study was the considerable out-
of-pocket costs of AES illness to families, being more than 5 times
their estimated monthly income. These costs rose to 10 times the
monthly income for families of children with moderate or severe
functional impairment. The estimated annual household income
per family member was US$ 230, considerably lower than the US$
490 estimated Gross National Income per capita for Nepal
reported by the World Bank for 2010 [36]. Typical of many health
problems, families with relatively low income may be dispropor-
tionately affected by AES illness in Nepal. In contrast, school
attendance rates among the parents were comparable to the
national rates reported in 2011, suggesting families of low
educational attendance were not disproportionately admitted to
hospital with AES [37].
This study has provided the first description of the out-of-pocket
costs experienced by families following AES. Given cases of AES
are more common than those with confirmed JE [1], describing
the costs linked to AES is especially important. Acute hospital
admission was the major cost, representing three-quarters of the
total out-of-pocket cost. Acute admission was also identified as the
major cost associated with JE illness in a Cambodian study that
interviewed affected families [28]. Among the 15 Nepali families
who were able to give a breakdown of admission costs, medication
Figure 4. Assessment of agreement between LOS and CASP
scores at follow-up among AES children. Bland-Altman plot
displays mean (x-axis) and difference (y-axis) in the mean LOS and CASP
score among the children with AES (n = 66) who had both scores
assessed at follow-up. Solid line indicates mean difference between the
two scores. Dotted lines indicate the limits of agreement (62 standard
deviations away from the mean difference). Sixty children (91%) had
scores for both the CASP and LOS that were within the limits of
agreement. Six children had significantly different scoring for the CASP
and LOS. Five children, plotting below the lower limit of agreement,
exhibited a relatively low CASP score compared to their LOS. One child,
plotting above the upper limit of agreement, exhibited a relatively high
CASP score compared to their LOS. Reviewing the individual scores for
the former 5 children identified that they experienced other factors
beyond functional impairments recognised via the LOS that limited
their social participation (Results).
doi:10.1371/journal.pntd.0002383.g004
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was the main expense, representing over half the acute admission
cost. Similarly, medication was identified to be the predominant
acute medical cost associated with JE illness in Indonesia [25].
This study is unique, in that functional assessment and out-of-
pocket costs were collected alongside one another. This allowed us
to demonstrate, that children with severe/moderate functional
impairment reported higher admission costs than those with mild/
no impairment. These costs are probably due to the children being
more severely unwell and having a longer admission. Although
attempts to rationalise acute hospital treatment should be balanced
against the needs of patients and medical staff to explore all
reasonable avenues of treatment, a more detailed analysis of acute
costs may help determine where hospital treatment could be
streamlined. Acute bacterial meningitis can have overlapping
clinical features with AES. Herpes simplex virus encephalitis is also
an infrequent cause of AES in Asia [7]. Beyond these exceptions,
there is no specific drug treatment for patients presenting with
AES. Enhancing diagnostic exclusion of these conditions may help
rationalise the use of medication among patients hospitalised with
AES. In turn, this could significantly reduce the economic impact
to families. The relatively low post-discharge out-of-pocket costs to
families in Nepal are in line with previous findings from Cambodia
[28]. These low costs may reflect limited access to services for
children following encephalitis.
Over three-quarters of families reported maintenance of their
child’s social participation following AES; the majority (84%) of
school age children, including half of the children with moderate
or severe functional impairments continued to attend full-time
education. A similar proportion of children attended school in
Cambodia and Vietnam following JE [35]. A slightly lower
proportion of school attendance (75%) was reported among
Malaysian children following JE [11]. The latter may reflect the
longer period of follow-up (up to 8 years) undertaken in the study
or a different attitude to social participation among the population.
Overall, the results of the CASP questionnaire showed good
agreement with the LOS. The good agreement between these
outcome scales implies that children with high functional ability
(high LOS) following AES illness also tend to have a high level of
social participation (high CASP). However, several children (n= 5)
had a low level of social participation despite a high LOS. These
children suffered behavioural disturbance, visual impairment or
changes in their external environment (such as family financial
difficulties) since the AES illness that limited their social
participation. The findings demonstrate that the CASP score
can identify children at risk of poor social participation that would
otherwise not be detected based solely on their level of functional
impairment. To our knowledge, there are no other publications
comparing these two scales.
On the whole, Nepali families appeared to have a positive
attitude towards social engagement of their child within the
community. More detailed research on the families’ attitudes to
social participation is now warranted. With further work, a
modified CASP score could be a useful tool for assessing social
participation in children with disabilities in a low resource setting.
There were several limitations to this study. The main reason
for loss of follow-up was inability to contact the family by phone.
Follow-up may have been improved by linking with community
health care teams to contact families directly. There was a higher
median age in those who were followed up than those who were
not. As only one family declined assessment, we are unable to
provide a reason for this finding. We assumed the carers’ responses
to the questionnaires were valid. We did not collect additional
indicators (e.g. responses from the child or school teacher) to
authenticate these reports. Carers recalled out-of-pocket costs from
the hospital admission several months previous. More accurate
costs and detail about what specific medical expenses were
incurred may have been obtained by gathering information during
the child’s acute admission.
In conclusion, although attention has been focussed on JE, AES
causes considerable prolonged functional impairment to children,
with substantial out-of-pocket costs to the family. Consideration
towards the cost of in-patient treatment may reduce the economic
impact to families, and release funds for hospital follow-up,
community services and rehabilitation following AES. Further
research involving local health professionals and carers would
identify which services would be most useful to AES patients long-
term and help to determine how best to support community health
services for these children.
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